论文部分内容阅读
[目的]观察马来酸曲美布汀(商品名:双迪)联合四逆散加减治疗肠易激综合征(IBS)的疗效。[方法]60例IBS患者随机分为2组,治疗组40例予马来酸曲美布汀联合四逆散加减治疗;对照组20例单用马来酸曲美布汀治疗。[结果]治疗组总有效率92.5%,优于对照组的85.0%(P<0.05)。治疗组缓解腹痛和便秘症状亦优于对照组(均P<0.05)。[结论]马来酸曲美布汀联合四逆散加减治疗IBS疗效较为理想。
[Objective] To observe the curative effect of trimebutine maleate (trade name: Di Di) combined with Sini Powder in the treatment of irritable bowel syndrome (IBS). [Method] Sixty patients with IBS were randomly divided into two groups. Treated group was treated with trimebutine maleate and Sini Powder. In the control group, 20 patients were treated with trimebutine maleate alone. [Results] The total effective rate was 92.5% in the treatment group, which was better than 85.0% in the control group (P <0.05). The treatment group relieved the symptoms of abdominal pain and constipation also better than the control group (all P <0.05). [Conclusion] Trimebutine maleate combined with Sini Powder for the treatment of IBS is more effective.